Neosynephrine (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Neosynephrine, is a sympathomimetic (α1‑adrenergic agonist) presented as a nasal formulation for intranasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Neosynephrine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neosynephrine acts on the nasal mucosa to alleviate congestion caused by upper‑respiratory conditions.

- Common cold nasal congestion: reduces swelling of nasal passages to improve airflow. - Sinusitis‑related congestion: decreases mucosal edema, facilitating sinus drainage. - Allergic rhinitis: constricts dilated nasal vessels, easing breathing during allergic episodes.

Phenylephrine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation. - Mild headache. - Transient increase in blood pressure. - Dryness of the nasal mucosa. - Sneezing. - Dizziness.

Serious or Rare Side Effects: - Severe hypertension. - Cardiac arrhythmia. - Reflex bradycardia. - Allergic reaction (rash, itching, swelling). - Nasal septum perforation with prolonged misuse. - Acute angle‑closure glaucoma in susceptible individuals.

Before using Neosynephrine, consider the following safety measures.

- Cardiovascular disease: avoid if you have uncontrolled hypertension or heart disease. - Thyroid disorders: use with caution in hyperthyroidism. - Diabetes: monitor blood glucose as vasoconstriction may affect levels. - Pregnancy and lactation: consult a healthcare professional before use. - Age restrictions: not recommended for children under 6 years without medical advice. - Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Phenylephrine can interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: additive vasoconstrictive effect. - β‑blockers: may blunt cardiovascular response.

Moderate Interactions (Monitor Closely): - Other nasal decongestants: increased risk of rebound congestion. - Diuretics: may enhance blood‑pressure‑raising effect. - Herbal stimulants (e.g., ephedra): potential for excessive sympathetic stimulation.